BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 33025766)

  • 1. A Review on Drug-Induced Nephrotoxicity: Pathophysiological Mechanisms, Drug Classes, Clinical Management, and Recent Advances in Mathematical Modeling and Simulation Approaches.
    Mody H; Ramakrishnan V; Chaar M; Lezeau J; Rump A; Taha K; Lesko L; Ait-Oudhia S
    Clin Pharmacol Drug Dev; 2020 Nov; 9(8):896-909. PubMed ID: 33025766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-Induced Nephrotoxicity: Pathogenic Mechanisms, Biomarkers and Prevention Strategies.
    Wu H; Huang J
    Curr Drug Metab; 2018; 19(7):559-567. PubMed ID: 29119923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication-Induced Nephrotoxicity in Older Patients.
    Fusco S; Garasto S; Corsonello A; Vena S; Mari V; Gareri P; Ruotolo G; Luciani F; Roncone A; Maggio M; Lattanzio F
    Curr Drug Metab; 2016; 17(6):608-25. PubMed ID: 27048182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection, Monitoring, and Mitigation of Drug-Induced Nephrotoxicity: A Pragmatic Approach.
    Antognini N; Portman R; Dong V; Webb NJ; Chand DH
    Ther Innov Regul Sci; 2024 Mar; 58(2):286-302. PubMed ID: 38110788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unveiling drug induced nephrotoxicity using novel biomarkers and cutting-edge preventive strategies.
    Džidić-Krivić A; Sher EK; Kusturica J; Farhat EK; Nawaz A; Sher F
    Chem Biol Interact; 2024 Jan; 388():110838. PubMed ID: 38104745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabonomics for discovering biomarkers of hepatotoxicity and nephrotoxicity.
    Zhang A; Sun H; Wang P; Han Y; Wang X
    Pharmazie; 2012 Feb; 67(2):99-105. PubMed ID: 22512077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-induced nephrotoxicity: clinical impact and preclinical in vitro models.
    Tiong HY; Huang P; Xiong S; Li Y; Vathsala A; Zink D
    Mol Pharm; 2014 Jul; 11(7):1933-48. PubMed ID: 24502545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-induced acute kidney injury.
    Schetz M; Dasta J; Goldstein S; Golper T
    Curr Opin Crit Care; 2005 Dec; 11(6):555-65. PubMed ID: 16292059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-induced nephrotoxicity. Aetiology, clinical features and management.
    Hoitsma AJ; Wetzels JF; Koene RA
    Drug Saf; 1991; 6(2):131-47. PubMed ID: 2043284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell- and biomarker-based assays for predicting nephrotoxicity.
    Huang JX; Blaskovich MA; Cooper MA
    Expert Opin Drug Metab Toxicol; 2014 Dec; 10(12):1621-35. PubMed ID: 25382677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nephrotoxins and nephrotoxic acute kidney injury.
    Uber AM; Sutherland SM
    Pediatr Nephrol; 2020 Oct; 35(10):1825-1833. PubMed ID: 31646405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential nephrotoxicity of sofosbuvir-based treatment in patients infected with hepatitis C virus: a review on incidence, type and risk factors.
    Dashti-Khavidaki S; Khalili H; Nasiri-Toosi M
    Expert Rev Clin Pharmacol; 2018 May; 11(5):525-529. PubMed ID: 29533117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminoglycoside nephrotoxicity.
    Appel GB
    Am J Med; 1990 Mar; 88(3C):16S-20S; discussion 38S-42S. PubMed ID: 2180292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-Induced Kidney Injury in the Elderly.
    Khan S; Loi V; Rosner MH
    Drugs Aging; 2017 Oct; 34(10):729-741. PubMed ID: 28815461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Earlier recognition of nephrotoxicity using novel biomarkers of acute kidney injury.
    Waring WS; Moonie A
    Clin Toxicol (Phila); 2011 Oct; 49(8):720-8. PubMed ID: 21970770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug nephrotoxicity].
    Izzedine H
    Nephrol Ther; 2018 May; 14(3):127-134. PubMed ID: 29540291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclosporine nephrotoxicity.
    Burdmann EA; Andoh TF; Yu L; Bennett WM
    Semin Nephrol; 2003 Sep; 23(5):465-76. PubMed ID: 13680536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Drug Monitoring Coupled With Bayesian Forecasting Could Prevent Vancomycin-Associated Nephrotoxicity in Renal Insufficiency Patients: A Prospective Study and Pharmacoeconomic Analysis.
    Zhang Y; Wang T; Zhang D; You H; Dong Y; Liu Y; Du Q; Sun D; Zhang T; Dong Y
    Ther Drug Monit; 2020 Aug; 42(4):600-609. PubMed ID: 32097248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Challenges in diagnosing acute calcineurin-inhibitor induced nephrotoxicity: from toxicogenomics to emerging biomarkers.
    Pallet N; Djamali A; Legendre C
    Pharmacol Res; 2011 Jul; 64(1):25-30. PubMed ID: 21473913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolomics approaches for discovering biomarkers of drug-induced hepatotoxicity and nephrotoxicity.
    Beger RD; Sun J; Schnackenberg LK
    Toxicol Appl Pharmacol; 2010 Mar; 243(2):154-66. PubMed ID: 19932708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.